Trial Profile
A Multi-centre, Observational Study to Evaluate the Incidence of Non-serious Rash in Korean Bipolar I Patients With Lamotrigine Therapy in Real World Setting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar I disorders
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 20 Jun 2007 New trial record.